Levels of DVBL in kidney of mice receiving VBL alone or in combination with different RA
| Drug | Time after treatment | ||
|---|---|---|---|
| 4 hr | 8 hr | 24 hr | |
| Control | 0.14 ± 0.01 | 0.18 ± 0.01 | 0.05 ± 0.001 |
| CSA (25 mg) | 0.23 ± 0.0012-b | 0.21 ± 0.02 | 0.29 ± 0.022-b |
| TFP (12.5 mg) | 0.12 ± 0.01 | 0.14 ± 0.01 | 0.14 ± 0.022-b |
| TFP (25 mg) | 0.14 ± 0.001 | 0.15 ± 0.02 | 0.16 ± 0.012-b |
| TFP (50 mg) | 0.11 ± 0.01 | 0.19 ± 0.02 | 0.20 ± 0.022-b |
| QND (50 mg) | 0.23 ± 0.022-b | 0.16 ± 0.02 | 0.05 ± 0.001 |
| VER (25 mg) | 0.29 ± 0.022-b | 0.41 ± 0.0042-b | 0.08 ± 0.01 |
2-a P < .05 vs. controls, Duncan’s test.
↵2-b P < .01 vs controls, Duncan’s test.